e-ISSN: 2320-0812

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Review Article Open Access

A Review on Bevacizumab: An Anti-Cancer Drug

Abstract

Cancer is one of the most wide spread diseases. Now-a-days, due to the advanced technologies drug for different kinds of cancer are available in the market. Bevacizumab (Avastin) is a one of the well-known anti-cancer drug which is used for different kinds of cancer. Bevacizumab (Avastin) interferes with growth of the cancerous cells. It is a humanized monoclonal antibody drug which blocks angiogenesis by inhibiting Vascular Endothelial Growth Factor A (VEGF-A). Researchers have shown the advantages of this drug in metastatic breast cancer, in blindness, ovarian cancer and many more. Before using this drug, patient should consult to the doctor and should be aware of its side effects in the future.

Jyotsna Jangra

To read the full article Download Full Article | Visit Full Article